SS
IRD

SBI Securities’s Opus Genetics IRD Stock Holding History

SBI Securities’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06K Sell
501
-29
-5% -$135 ﹤0.01% 2551
2026
Q1 		$2.41K Sell
530
-2,044
-79% -$7.07K ﹤0.01% 2357
2025
Q4 		$5.17K Sell
2,574
-8
-0.3% -$16 ﹤0.01% 2006
2025
Q3 		$4.26K Sell
2,582
-1,000
-28% -$1.24K ﹤0.01% 2115
2025
Q2 		$3.38K Hold
3,582
– – ﹤0.01% 2169
2025
Q1 		$3.52K Sell
3,582
-21,378
-86% -$23.9K ﹤0.01% 2042
2024
Q4 		$29.7K Buy
+24,960
New +$28.7K ﹤0.01% 1179

Other funds holding IRD

MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
FCCM
First City Capital Management Savannah, Georgia $206M AUM 26.13% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
HHCP
Hilton Head Capital Partners Hilton Head Island, South Carolina $198M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

SBI Securities's IRD Position: Q2 2026 in Review

SBI Securities reduced its Opus Genetics (IRD) stake by 5.5% in Q2 2026, selling an estimated $135 and leaving 501 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #2551.

SBI Securities first reported a position in IRD in Q4 2024 and has held it in 7 quarters since. The position peaked at $29.7K in Q4 2024. 14 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • SBI Securities held 501 shares of Opus Genetics worth $2.06K as of Q2 2026.
  • SBI Securities sold 29 Opus Genetics shares in Q2 2026, an estimated $135.
  • Opus Genetics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2551 holding.
  • SBI Securities first reported a position in Opus Genetics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Opus Genetics position peaked at $29.7K in Q4 2024.
  • 14 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.